Fibrobiologics’ artificial thymus organoid restores immune function in SCID mouse model

June 26, 2024

Fibrobiologics Inc. has announced the development of a novel artificial thymus organoid that can restore immune function in a severe combined immunodeficiency (SCID) mouse model.

BioWorld Science Drug design, drug delivery and technologies Organoids Aging Immune

Today's news in brief

BioWorld

BioWorld briefs for March 31, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for March 31, 2025

Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal

BioWorld Science

As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...

Corcept looks to NDA following strong phase III ovarian cancer data

BioWorld

Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...

Marks’ departure intensifies regulatory uncertainty at US FDA

BioWorld

Peter Marks’ March 28 letter giving one week’s notice of his resignation as director of the U.S. FDA’s Center for Biologics Evaluation and Research (CBER) is...